Skip to main content Accessibility help
  • Print publication year: 2011
  • Online publication date: March 2012

Chapter 66 - Metastatic disease

from Section 3 - Symptomatic epilepsy


Polymicrogyria has been related to mutations of several genes including SRPX2, PAX6, TBR2, KIAA1279, RAB3GAP1, COL18A1 and copy-number variations. The spectrum of clinical manifestations associated with polymicrogyria ranges from normal individuals with only selective impairment of cognitive functions. Generalized polymicrogyria is often accompanied by microcephaly and severe-profound cognitive and motor delay, as well as epilepsy. Both polymicrogyria and schizencephaly have been reported in the same family and both may occur with prenatal cytomegalovirus infection. Clinical findings include focal seizures present in most patients usually beginning before age 3 years if bilateral clefts are present. Epilepsy, motor impairment, and disorders of higher cortical functions are the most common clinical manifestation of polymicrogyria. Specific electroclinical features of Aicardi syndrome include early onset infantile spasms and partial seizures. Electroencephalography in polymicrogyria and schizencephaly shows variable patterns of abnormality. Selected patients with schizencephaly have been treated with surgery for epilepsy.

Related content

Powered by UNSILO


American Cancer Society (2008) Cancer facts and figures 2008. Available online at and_figures_2008.asp
Barnholtz-Sloan JS, Sloan JE, Davis FG, et al. (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865–72.
Cannon WB (1939) A law of denervation. Am J Med Sci 198:737–50.
Chamberlain MC (1997) Carcinomatous meningitis. Arch Neurol 44:16–17.
Chamberlain MC (2008) Neoplastic meningitis. Curr Neurol Neurosci Rep 8:249–58.
Chiang AC, Massagué J (2008) Molecular basis of metastasis. N Engl J Med 359:2814–23.
Delattre J-Y, Krp G, Thaler HT, Posner JB (1988) Distribution of brain metastases. Arch Neurol 45:741–4.
Del Maestro RF (1980) An approach to free radicals in medicine and biology. Acta Physiol Scand (Suppl) 492:153–68.
Fish DR (1999) How do tumors cause epilepsy? In: Kotagal P Lüders HD (eds.) The Epilepsies: Etiologies and Prevention. L San Diego, CA: Academic Press, pp. 301–14.
Fogelholm R, Uutela T, Murros K (1984) Epidemiology of central nervous system neoplasms: a regional survey in Central Finland. Acta Neurol Scand 69:129–36.
Forsyth PA, Weaver S, Fulton D, et al. (2003) Prophylactic anticonvulsants in patients with brain tumor. Can J Neurol Sci 30:106–12.
Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5–14.
Glantz MJ, Cole BF, Forsyth PA, et al. (2000) Practice parameters: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886–93.
Guomundsson KR (1970) A survey of tumors of the central nervous system in Iceland during the 10-year period 1954–1963. Acta Neurol Scand 46:538–52.
Herman ST (2002) Epilepsy after brain insult. targeting epileptogenesis. Neurology 59:S21–6.
Hoffman SN, Salin PA, Prince DA (1994) Chronic neocortical epileptogenesis in vitro. J Neurophys 71:1762–73.
Kalkanis SN, Linskey ME (2010) Evidence-based clinical practice parameter guidelines for the treatment of patients with metastatic brain tumors: introduction. J Neurooncol 96:7–10.
Kalkanis SN, Kondziolka D, Gaspar LE, et al. (2010) The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelines. J Neurooncol 96:33–43.
Kaplan JG, DeSouza TG, Farkash A, et al. (1990) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 9:225–9.
Klein M, Engelberts NHJ, van der Ploeg S (2003) Epilepsy in low-grade gliomas: the impact on cognitive and quality of life. Ann Neurol 54:514–20.
Linskey ME, Andrews DW, Asher AL, et al. (2010) The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastasis: a systematic review and evidence-based clinical practice guidelines. J Neurooncol 96:45–68.
Maschio M, Dinapoli L, Zarabla A, Jandolo B (2006) Issues related to the pharmacological management of patients with brain tumors and epilepsy. Funct Neurol 21:15–19.
Mehta MP, Paleologos NA, Mikkelsen T, et al. (2010) The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:71–83.
Mendez IM, Del Maestro RF (1988) Cerebral metastases from malignant melanoma. Can J Neurol Sci 15:119–23.
Mikkelsen T, Paleologos NA, Robinson PD, et al. (2010) The role of prophylactic anticonvulsants in the management of brain metastases: a systemic review and evidence-based clinical practice guideline. J Neurooncol 96:97–102.
Olson JJ, Paleologos NA, Gaspar LE, et al. (2010) The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics. J Neurooncol 96:115–42.
Percy AK, Elveback LR, Okazaki H, Kurland LT (1972) Neoplasms of the central nervous system: epidemiologic considerations. Neurology 22:40–8.
Perry J, Zinman L, Chambers A, et al. (2006) The use of prophylactic anticonvusants in patients with brain tumors: a systematic review. Curr Oncol 13:222–9.
Posner JB (1995) Brain metastases. J Neurooncol 27:287–93.
Ries LAG, Eisner MP, Kosary CL (eds.) (2003) SEER Cancer Statistics Review, 1975–2000 Bethesda, MD: National Cancer Institute. Available online at
Ryken TC, McDermott M, Robinson PD, et al. (2010) The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:103–4.
Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: a metanalysis. Mayo Clin Proc 79:1489–94.
Walker RA, Robins M, Weinfeld FD (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:219–26.
Van Breeman MSM, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumors: epidemiology, mechanisms and management. Lancet Neurol 6:421–30.
Willmore LJ, Ueda Y (2009) Posttraumatic epilepsy: hemorrhage, free radicals and the molecular regulation of glutamate. Neurochem Res 34:688–97.
Wong W, Stewart CE, Desmond PM (2009) Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of q, p, L, and fractional anisotropy. AJNR Am J Neuroradiol 30:203–8.
Villemure JG, De Tribolet N (1996) Epilepsy in patients with central nervous system tumors. Curr Opin Neurol 9:424–8.